EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The role of interleukin-33 in organ fibrosis

Samuele Di Carmine, Molly M Scott, Mairi H McLean, Henry J McSorley iD

Discovery Immunology · 2022

DOI: 10.1093/discim/kyac006 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Discovery Immunology, 2022. Verfasst von Samuele Di Carmine und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cell Signalling and Immunology, School of Life Sciences, Wellcome Trust Building, University of Dundee, Dundee, UK. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 131 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Molly M Scott, Samuele Di Carmine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Interleukin (IL)-33 is highly expressed in the nucleus of cells present at barrier sites and signals via the ST2 receptor. IL-33 signalling via ST2 is essential for return to tissue homeostasis after acute inflammation, promoting fibrinogenesis and wound healing at injury sites. However, this wound-healing response becomes aberrant during chronic or sustained inflammation, leading to transforming growth factor beta (TGF-β) release, excessive extracellular matrix deposition, and fibrosis. This review addresses the role of the IL-33 pathway in fibrotic diseases of the lung, liver, gastrointestinal tract, skin, kidney and heart. In the lung and liver, IL-33 release leads to the activation of pro-fibrotic TGF-β, and in these sites, IL-33 has clear pro-fibrotic roles. In the gastrointestinal tract, skin, and kidney, the role of IL-33 is more complex, being both pro-fibrotic and tissue protective. Finally, in the heart, IL-33 serves cardioprotective functions by favouring tissue healing and preventing cardiomyocyte death. Altogether, this review indicates the presence of an unclear and delicate balance between resolving and pro-fibrotic capabilities of IL-33, which has a central role in the modulation of type 2 inflammation and fibrosis in response to tissue injury.

Schlagwörter

Stichwörter der Autor:innen

IL-33acute injurychronic injuryfibrosiswound healing

Autor:innen und Institutionen

  • Division of Cell Signalling and Immunology, School of Life Sciences, Wellcome Trust Building, University of Dundee, Dundee, UK.
  • Division of Molecular and Clinical Medicine, School of Medicine, University of Dundee, Ninewells Hospital, Dundee, UK.

ORCID-Profile: Henry J McSorley

Förderung

  • Molly M Scott
  • Samuele Di Carmine

Zitieren

APA

Di Carmine, S., Scott, M. M., McLean, M. H., & McSorley, H. J. (2022). The role of interleukin-33 in organ fibrosis. Discovery Immunology. https://doi.org/10.1093/discim/kyac006

Vancouver

Di Carmine S, Scott MM, McLean MH, McSorley HJ. The role of interleukin-33 in organ fibrosis. Discovery Immunology. 2022. doi:10.1093/discim/kyac006

BibTeX
@article{DiCarmine2022,
  author = {Di Carmine, Samuele and Scott, Molly M and McLean, Mairi H and McSorley, Henry J},
  title = {The role of interleukin-33 in organ fibrosis},
  journal = {Discovery Immunology},
  year = {2022},
  doi = {10.1093/discim/kyac006}
}
Kostenlos starten →